Key Takeaways
- • CVC Capital Partners appoints Todd Sisitsky, TPG's president and head of global private equity, as co-CEO effective Q1 2028, signaling a planned leadership transition from incumbent Rob Lucas following the firm's 2024 IPO.
- • Sisitsky will share the CEO role with Peter Rutland, CVC's president and head of financial services investments, and will also assume the chair position as part of a long-term succession plan.
- • The appointment brings 25+ years of private markets experience to CVC's leadership, with Sisitsky having built a track record in healthcare investing at TPG, including Par Pharmaceutical, Allogene, and IQVIA.
- • Rob Lucas will remain at CVC post-transition and continue serving as a key person on multiple private equity funds, ensuring continuity during the leadership change.
- • The move reflects CVC's strategic expansion beyond traditional private equity into private credit, infrastructure, and secondaries—areas where the incoming co-CEO will help drive growth.
Summary
CVC Capital Partners has announced the appointment of Todd Sisitsky as co-chief executive, effective in the first quarter of 2028, according to the Financial Times. Sisitsky, currently president and head of global private equity at TPG, will share the CEO role with Peter Rutland, CVC's president and head of financial services investments. As part of the succession plan, Sisitsky will also become chair of the firm. The appointment represents a significant external hire into CVC's senior leadership ranks and signals the planned departure of current CEO Rob Lucas, who has led the firm since its 2024 initial public offering.
Sisitsky brings substantial alternative investment expertise to CVC, having spent more than two decades at TPG since 2003. At TPG, he rose to become one of the firm's leading healthcare investors and ultimately achieved the position of second-ranking executive behind CEO Jon Winkelried. His healthcare portfolio at TPG includes notable investments in Par Pharmaceutical, Allogene, and IQVIA. He has stepped down from his roles as president and board member at TPG effective immediately and will leave the firm to join CVC.
Rob Lucas will remain with CVC following his transition out of the CEO role and is expected to continue as a key person on a number of CVC's private equity funds, providing continuity through the leadership change. Peter Rutland, who has spent nearly two decades at CVC, will anchor the leadership team alongside Sisitsky, delivering internal stability during the transition period. This dual-co-CEO structure pairs external expertise with established internal knowledge of CVC's operations and culture.
The appointment aligns with CVC's strategic evolution beyond its traditional private equity base. In recent years, the firm has significantly broadened its platform through acquisitions including Marathon Asset Management (private credit), DIF (infrastructure), and Glendower Capital (secondaries). Sisitsky's appointment signals CVC's intent to leverage his capital deployment experience across these expanding investment verticals as the firm continues to diversify its revenue streams and asset base.
Sisitsky brings substantial alternative investment expertise to CVC, having spent more than two decades at TPG since 2003. At TPG, he rose to become one of the firm's leading healthcare investors and ultimately achieved the position of second-ranking executive behind CEO Jon Winkelried. His healthcare portfolio at TPG includes notable investments in Par Pharmaceutical, Allogene, and IQVIA. He has stepped down from his roles as president and board member at TPG effective immediately and will leave the firm to join CVC.
Rob Lucas will remain with CVC following his transition out of the CEO role and is expected to continue as a key person on a number of CVC's private equity funds, providing continuity through the leadership change. Peter Rutland, who has spent nearly two decades at CVC, will anchor the leadership team alongside Sisitsky, delivering internal stability during the transition period. This dual-co-CEO structure pairs external expertise with established internal knowledge of CVC's operations and culture.
The appointment aligns with CVC's strategic evolution beyond its traditional private equity base. In recent years, the firm has significantly broadened its platform through acquisitions including Marathon Asset Management (private credit), DIF (infrastructure), and Glendower Capital (secondaries). Sisitsky's appointment signals CVC's intent to leverage his capital deployment experience across these expanding investment verticals as the firm continues to diversify its revenue streams and asset base.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.